NovoCure Limited (NVCR) financial statements (2022 and earlier)

Company profile

Business Address NO. 4 THE FORUM
ST. HELIER, JE2 4UF
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments938843326246183220269
Cash and cash equivalents20923517714179100119
Short-term investments729608149105105120150
Restricted cash and investments11122200
Receivables94975937306 
Inventory, net of allowances, customer advances and progress billings24272423222614
Inventory24272423222614
Prepaid expense5424321
Other undisclosed current assets121727115810
Total current assets:1,074999440321245262294
Noncurrent Assets
Operating lease, right-of-use asset1819 
Property, plant and equipment2311989107
Other noncurrent assets121153221
Defined benefit plan, assets for plan benefits64
Other undisclosed noncurrent assets1311257932
Total noncurrent assets:66534018202013
TOTAL ASSETS:1,1391,052479340265282307
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities119916343312626
Accounts payable73543727171817
Accrued liabilities7750001
Employee-related liabilities403021171388
Debt   0000
Other undisclosed current liabilities2423242120113
Total current liabilities:1431148665503729
Noncurrent Liabilities
Long-term debt and lease obligation575444149149979623
Long-term debt, excluding current maturities562430149149979623
Operating lease, liability1314 
Liabilities, other than long-term debt7122413243
Deferred revenue612 
Contract with customer, liability8 
Liability, pension and other postretirement and postemployment benefits  1612   
Other liabilities0001243
Other undisclosed noncurrent liabilities5520232
Total noncurrent liabilities:58646217516310210328
Total liabilities:72957526222815214057
Stockholders' equity
Stockholders' equity attributable to parent410477218112114142251
Additional paid in capital1,1001,111871757697664640
Accumulated other comprehensive loss(3)(4)(3)(1)(1)(2)(2)
Accumulated deficit(686)(631)(651)(644)(582)(520)(388)
Total stockholders' equity:410477218112114142251
TOTAL LIABILITIES AND EQUITY:1,1391,052479340265282307

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues5354943512481778333
Revenue, net1778333
Cost of revenue(115)(107)(89)(80)(56)(40)(21)
Cost of goods and services sold(1)(1)(0)(2)(7)(10)(1)
Other undisclosed gross profit     (6) 
Gross profit:4203882631681213712
Operating expenses(464)(357)(264)(202)(161)(152)(116)
Operating income (loss):(44)30(1)(34)(39)(115)(104)
Interest and debt expense(8)(12)(8)(12)(9)(6)(3)
Income (loss) from continuing operations before income taxes:(52)18(9)(46)(48)(121)(107)
Income tax expense (benefit)(6)22(18)(13)(10)(4)
Net income (loss) available to common stockholders, diluted:(58)20(7)(64)(62)(132)(112)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(58)20(7)(64)(62)(132)(112)
Other comprehensive income (loss)1(1)(1)(0)1(0)(2)
Comprehensive income (loss), net of tax, attributable to parent:(58)19(9)(64)(61)(132)(113)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: